abrdn Investment Management’s AbbVie ABBV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q2
$20.4M Sell
281,085
-4,910
-2% -$330K 0.07% 148
2017
Q1
$18.6M Sell
285,995
-17,677
-6% -$1.11M 0.06% 147
2016
Q4
$19M Sell
303,672
-2,881
-0.9% -$176K 0.07% 143
2016
Q3
$19.3M Buy
306,553
+150,802
+97% +$9.76M 0.08% 142
2016
Q2
$9.64M Sell
155,751
-3,446,214
-96% -$210M 0.04% 149
2016
Q1
$206M Sell
3,601,965
-435,384
-11% -$24.3M 0.94% 45
2015
Q4
$239M Sell
4,037,349
-113,078
-3% -$6.51M 1.01% 38
2015
Q3
$226M Sell
4,150,427
-102,340
-2% -$6.66M 0.97% 40
2015
Q2
$286M Sell
4,252,767
-641,612
-13% -$41.9M 1.21% 33
2015
Q1
$286M Sell
4,894,379
-218,159
-4% -$13.2M 1.17% 34
2014
Q4
$335M Sell
5,112,538
-524,939
-9% -$33.1M 1.32% 31
2014
Q3
$326M Buy
5,637,477
+1,403,020
+33% +$77.9M 1.24% 32
2014
Q2
$239M Sell
4,234,457
-465,229
-10% -$24.4M 1.07% 34
2014
Q1
$242M Buy
4,699,686
+1,135,382
+32% +$57.4M 1.15% 30
2013
Q4
$188M Buy
3,564,304
+2,553,160
+253% +$125M 1% 36
2013
Q3
$45.2M Buy
1,011,144
+698,583
+224% +$31M 0.26% 94
2013
Q2
$12.9M Buy
+312,561
New +$13.7M 0.08% 138

Other funds holding ABBV

abrdn Investment Management's ABBV Position: Q2 2017 in Review

abrdn Investment Management reduced its AbbVie (ABBV) stake by 1.7% in Q2 2017, selling an estimated $330K and leaving 281,085 shares worth $20.4M. The position accounts for 0.07% of the portfolio, ranked #148.

abrdn Investment Management first reported a position in ABBV in Q2 2013 and has held it in 17 quarters since. The position peaked at $335M in Q4 2014. 1,763 funds tracked by Wall St. Rank hold ABBV as of Q2 2017.

  • abrdn Investment Management held 281,085 shares of AbbVie worth $20.4M as of Q2 2017.
  • abrdn Investment Management sold 4,910 AbbVie shares in Q2 2017, an estimated $330K.
  • AbbVie made up 0.07% of abrdn Investment Management's portfolio in Q2 2017, its #148 holding.
  • abrdn Investment Management first reported a position in AbbVie in Q2 2013 and has held it in 17 quarters since.
  • abrdn Investment Management's AbbVie position peaked at $335M in Q4 2014.
  • 1,763 funds tracked by Wall St. Rank held AbbVie as of Q2 2017.

Based on abrdn Investment Management's 13F filing for Q2 2017, filed 10 Aug 2017.